Global Fertility Testing Devices Market Is Poised To Grow At A CAGR Of 7.5% During The Forecast Period To Reach USD 216.8 Million By 2020

Major Factor For The Growth of Fertility Testing Devices Market :
The emergence of advanced and easy-to-use ovulation monitors with high accuracy, rising median age of first-time pregnancies in women, and increasing awareness about fertility testing are driving the growth of the market. In addition, factors such as declining fertility rate among women across the globe and easy availability of ovulation monitors on e-commerce websites are further stimulating the growth of the market.

Download PDF  Brochure: http://bit.ly/2hZdK0c

The global Fertility Testing Devices  market is poised to grow at a CAGR of 7.5% during the forecast period and expected to reach a value of USD 216.8 Million by 2020.

Market Geography :

Fertility Testing Devices  market is divided into North America (comprising the U.S. and Canada), Europe (comprising Germany, U.K., France, and the Rest of Europe), Asia-Pacific, and the Rest of the World.

Key Players :

Fertility Testing Devices  market include SPD Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Brands Holdings, Inc. (U.S.), Fairhaven Health, LLC (U.S.), HiLin Life Products, Inc. (U.S.), Fertility Focus Limited (U.K.), and Geratherm Medical AG (Germany).

About Report :

The global Fertility Testing Devices  market is broadly categorized into two segments, namely, ovulation prediction kits and fertility monitors. The ovulation prediction kits segment accounts for the larger share of the global market, while the fertility monitors segment is expected to grow at the higher CAGR in the forecast period.

The high growth of this segment is driven by the high accuracy of fertility monitors, especially in women suffering from PCOS, and increase in the number of product launches of advanced fertility monitors. The fertility monitors segment includes saliva-based monitors, urine-based monitors, and others.

To Know More: Click Here

Current scenario and the future growth prospects of the “Cardiovascular Ultrasound System”

Major Factor Driving The Market Growth :

Increasing incidence of cardiovascular diseases, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures are the major drivers for the Cardiovascular Ultrasound System Market . However, insufficient reimbursement scenario and economic impact of adopting new technologies are restraining the growth of the market.

Download PDF Brochure: http://bit.ly/2eV9fiK

The Cardiovascular Ultrasound System Market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, growing at a CAGR of 5.4% during the forecast period (2016–2021)

Key players :

Key players in the Cardiovascular Ultrasound System Market  include GE Healthcare (U.S.), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).

About Report :

The Cardiovascular Ultrasound System Market  is broadly segmented into test type, technology, device display, end user, and region. Based on test type, the market is categorized into transthoracic echocardiogram, stress echocardiogram, transesophageal echocardiogram, and fetal & intracardiac echocardiogram. The stress echocardiogram segment is expected to account for the largest share of the market in 2016. This is due to the major advantage of the stress echocardiogram that it can provide data of the cardiac muscles and valves before and after the stress of the heart muscle.

On the basis of technology, the Cardiovascular Ultrasound System Market  is segmented into 2D, 3D & 4D, and Doppler imaging. The 2D technology is estimated to account for the largest share of the market in 2016, whereas the 3D & 4D technology segment is estimated to grow at the highest CAGR during the forecast period.

To Know More : http://bit.ly/2wZOVW1

FDA and Ce Mark Approvals Driving the Adoption of Surgical Sealants and Adhesives

Major Factor Which Are Driving The Growth Of Surgical Sealants and Adhesives Market :

Increasing incidence of chronic diseases along with the rapid growth in the geriatric population, increasing need manage blood loss in patients, and growing number of surgical procedures performed are the major factors driving the growth of the surgical sealants and adhesives market

                                                           

Get PDF Brochure Here : http://bit.ly/2hMM8eA

On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives. The natural/biological sealants and adhesives segment is further categorized into type and origin.

On the basis of type, the natural/biological sealants segment have been divided into polypeptide/protein-based and polysaccharide-based sealants and adhesives. The polypeptide/protein-based sealants segment is further categorized into fibrin, gelatin, collagen, and albumin-based adhesives, while the polysaccharide-based sealants segment comprise of chitosan-based and other polysaccharide-based adhesives.

 On the basis of origin, the natural/biological sealants and adhesives segment is categorized into human blood-based and animal-based. The synthetic and semi-synthetic sealants and adhesives segment is divided into cyanoacrylates, polyethylene glycol hydrogels, urethane-based adhesives, and other synthetic adhesives.

On the basis of application, the global surgical sealants and adhesives market is segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological, pulmonary, ophthalmic surgeries, and other applications.

To Know More : http://bit.ly/2fuaGZi

High Incidence Chronic Diseases Driving Viral Inactivation Testing Market

The global viral inactivation market was valued at USD 320.5 Million in 2016 and poised to grow at a CAGR of 12.3% between 2016 and 2021, to reach USD 573.0 Million in 2021

Download PDF Brochure Here: http://bit.ly/2y3dnoK

The Major Drivers For  Viral Inactivation Market :

Rapid growth in pharmaceutical and biotechnology industries and strong trend of R&D investments in life sciences industry. Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.

Target Audience for this Report:

• Viral inactivation product manufacturers and vendors
• Research associations related to pharmaceutical and biotechnological research
• contract research organizations (CROs)
• Various research and consulting firms
• Healthcare institutions
• Research institutes
• Distributors of viral inactivation equipment

Key Players :

Major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).

About Report :

The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. Of these the vaccines and therapeutics application hold the highest share.The product segments included in the report are kits and reagents, services, and viral inactivation systems and accessories.

To Know More : http://bit.ly/2jtcOBY

Adoption of Disposable Medical Sensors in Diagnostic Applications Across The World Owing To Their Varied Benefits

Factors Of Disposable Medical Device Sensors Market Growth :

Growing prevalence of diabetes and other infectious diseases across the globe, government support for research and development activities in medical sensors, various benefits such as faster analysis, low costs, ease of use, and rising needs to curtail escalating healthcare costs.

The Disposable Medical Device Sensors   market is poised to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period of 2015 to 2020.

Get PDF Brochure Here: http://bit.ly/2ybQEaz

Key Players:

Some of the major players in this market include Medtronic plc. (Ireland), GE Healthcare (U.K.), Philips N.V. (Netherlands), Smiths Medical (U.K.), TE Connectivity (Switzerland), Freescale Semiconductors, Inc. (U.S.), Omnivision Technologies, Inc. (U.S.), STMicroelectronics (Switzerland), Analog Devices, Inc. (U.S.), and Honeywell International, Inc. (U.S.).

About Report:

The Disposable Medical Device Sensors   market is segmented into patient monitoring devices, diagnostic testing devices, imaging devices, and therapeutic devices. The diagnostic testing devices segment is further divided into HIV test kits, pregnancy test kits, drug and alcohol test kits, and blood glucose test strips.

The therapeutic devices segment is further divided into insulin pump sensors, dialysis device sensors, cardiac therapy devices, and cardiac catheter sensors. The patient monitoring devices segment is categorized into continuous blood pressure monitors, pulse oximeters, cardiac monitors, continuous glucose monitoring devices, implantable loop recorders, smart pills, and others. The imaging devices segment is divided into capsule endoscopes and disposable endoscopes.

To Know More : http://bit.ly/2x6dEJC

Enteral feeding is a growing requirement among the rising geriatric population..!!

The Major Factor Driving and Restraining Market Growth :

The global enteral feeding formulas market is mainly driven by the rising incidences of chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare.

However, factors such as complications associated with enteral nutrition, patient safety risks, and the occurrence of feeding and medication errors are expected to restrain the growth of the enteral feeding formulas market to a certain extent.

Get PDF Brochure Here: http://bit.ly/2uxJHBx

The global enteral feeding formulas market is projected to reach USD 5.95 Billion by 2020, at a CAGR of 7.6% from 2015 to 2020.

Key players :

Some of the prominent players in the global Enteral Feeding Formulas Market  are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan)

About Report :

On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the Enteral Feeding Formulas Market  in 2015, primarily due to high prevalence of malnutrition among cancer patients.

To  Know More : http://bit.ly/2uuimAp

Advanced And Easy-To-Use Ovulation Monitor With High Accuracy ..!!

Major Factor For The Growth of Fertility Testing Devices Market :

The emergence of advanced and easy-to-use ovulation monitors with high accuracy, rising median age of first-time pregnancies in women, and increasing awareness about fertility testing are driving the growth of the market. In addition, factors such as declining fertility rate among women across the globe and easy availability of ovulation monitors on e-commerce websites are further stimulating the growth of the market. 

Download PDF  Brochure: http://bit.ly/2hZdK0c

The global Fertility Testing Devices  market is poised to grow at a CAGR of 7.5% during the forecast period and expected to reach a value of USD 216.8 Million by 2020.

Market Geography

Fertility Testing Devices  market is divided into North America (comprising the U.S. and Canada), Europe (comprising Germany, U.K., France, and the Rest of Europe), Asia-Pacific, and the Rest of the World.

Key Players

Fertility Testing Devices  market include SPD Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Brands Holdings, Inc. (U.S.), Fairhaven Health, LLC (U.S.), HiLin Life Products, Inc. (U.S.), Fertility Focus Limited (U.K.), and Geratherm Medical AG (Germany).

About Report

The global Fertility Testing Devices  market is broadly categorized into two segments, namely, ovulation prediction kits and fertility monitors. The ovulation prediction kits segment accounts for the larger share of the global market, while the fertility monitors segment is expected to grow at the higher CAGR in the forecast period. 

The high growth of this segment is driven by the high accuracy of fertility monitors, especially in women suffering from PCOS, and increase in the number of product launches of advanced fertility monitors. The fertility monitors segment includes saliva-based monitors, urine-based monitors, and others.

To Know More: http://bit.ly/2vUuaN0